Literature DB >> 25437278

Preclinical inflammatory rheumatic diseases: an overview and relevant nomenclature.

Karim Raza1, Danielle M Gerlag2.   

Abstract

Chronic inflammatory and autoimmune conditions result from an interplay between genetic and environmental factors culminating in the phenotypes of established disease. The transition from health to established disease is relatively well understood in rheumatoid arthritis (RA), which provides an exemplar for other diseases. This article addresses terminologies to describe the phases of disease leading to RA, disease initiation and the point from which disease duration should be timed, the future research agenda suggested by this approach to the definition of phases of disease, and the importance of capturing the patient perspective in research into the earliest phases of disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early; Preclinical; Prediction; Prevention; Rheumatoid arthritis; Risk

Mesh:

Year:  2014        PMID: 25437278     DOI: 10.1016/j.rdc.2014.07.001

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

Review 1.  Pre-rheumatoid arthritis and its prevention.

Authors:  Binoy J Paul; Hemanth Illath Kandy; Vinod Krishnan
Journal:  Eur J Rheumatol       Date:  2017-04-11

Review 2.  Pre-RA: Can early diagnosis lead to prevention?

Authors:  Salina Haville; Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2022-01-03       Impact factor: 4.098

3.  The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study.

Authors:  Arsenio Spinillo; Fausta Beneventi; Elena Locatelli; Vèronique Ramoni; Roberto Caporali; Claudia Alpini; Giulia Albonico; Chiara Cavagnoli; Carlomaurizio Montecucco
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-18       Impact factor: 3.007

Review 4.  Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.

Authors:  Danielle M Gerlag; Jill M Norris; Paul P Tak
Journal:  Rheumatology (Oxford)       Date:  2015-09-15       Impact factor: 7.580

Review 5.  Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?

Authors:  Alexander Tracy; Christopher D Buckley; Karim Raza
Journal:  Semin Immunopathol       Date:  2017-03-23       Impact factor: 9.623

6.  Boosting the Intra-Articular Efficacy of Low Dose Corticosteroid through a Biopolymeric Matrix: An In Vivo Model of Osteoarthritis.

Authors:  Matilde Tschon; Francesca Salamanna; Lucia Martini; Gianluca Giavaresi; Luca Lorenzini; Laura Calzà; Milena Fini
Journal:  Cells       Date:  2020-06-28       Impact factor: 6.600

7.  Accuracy of self-reported history of autoimmune disease: A pilot study.

Authors:  Julia A O'Rourke; Caitlin Ravichandran; Yamini J Howe; Jennifer E Mullett; Christopher J Keary; Sara B Golas; Amrita R Hureau; Morgan McCormick; Jeanhee Chung; Noel R Rose; Christopher J McDougle
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

8.  Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis.

Authors:  Marian van Beers-Tas; Markus Mj Nielen; Jos W R Twisk; Joke Korevaar; D van Schaardenburg
Journal:  RMD Open       Date:  2020-07

9.  The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis.

Authors:  Isabela Siloşi; Mihail Virgil Boldeanu; Manole Cojocaru; Viorel Biciuşcă; Vlad Pădureanu; Maria Bogdan; Ramona Georgiana Badea; Carmen Avramescu; Ileana Octavia Petrescu; Florin Petrescu; Cristian A Siloşi
Journal:  J Immunol Res       Date:  2016-08-04       Impact factor: 4.818

10.  Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project.

Authors:  Marian H van Beers-Tas; Marieke M Ter Wee; Lilian H van Tuyl; Bertha Maat; Wijnanda Hoogland; Aase H Hensvold; Anca I Catrina; Erika Mosor; Tanja A Stamm; Axel Finckh; Delphine S Courvoisier; Andrew Filer; Ilfita Sahbudin; Rebecca J Stack; Karim Raza; Dirkjan van Schaardenburg
Journal:  RMD Open       Date:  2018-05-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.